Search Results
Rivaroxaban for thromboprophylaxis in high-risk cancer patients: CASSINI results
Rivaroxaban for Thromboprophylaxis in High-Risk Ambulatory Patients with cancer
Alok A. Khorana: Rivaroxaban Thromboprophylaxis in High-Risk Ambulatory Cancer Patients
Rivaroxaban in high-risk ambulatory cancer patients receiving systemic therapy
Alok Khorana: Rivaroxaban Prevents Cancer-Associated VTE
Rivaroxaban for Thromboprophylaxis in High-Risk Ambulatory Patients with Cancer
Rivaroxaban for Thromboprophylaxis in High Risk Ambulatory Patients with Cancer
Rivaroxaban for thromboprophylaxis in high risk ambulatory patients with cancer
Updated ASCO guidelines for VTE in cancer
Rivaroxaban in Cancer-Associated VTE: Results from CALLISTO
How is cancer-related venous thromboembolism treated in real world practice?
Rivaroxaban for preventing venous thromboembolism in high-risk ambulatory patients with cancer
